Why is Venus Remedies falling/rising?

As of 28-Aug, Venus Remedies Ltd is experiencing a decline in its stock price, currently at Rs 462.00, which reflects a decrease of Rs 19.0 or 3.95%. The stock has underperformed its sector by 3.11% today and has been on a consecutive downward trend for the last three days, resulting in a total drop of 8.42% during this period. Despite a strong year-to-date return of 46.60% and a notable 30.31% increase over the past year, recent performance has been lackluster, with a 6.59% decline over the past week and a 9.94% drop in the last month. The stock's moving averages indicate it is currently lower than the 5-day, 20-day, and 50-day averages, although it remains above the 100-day and 200-day averages. Positive factors such as a low debt-to-equity ratio, consistent profit growth, and increasing institutional investor participation suggest a solid foundation, but these have not been enough to counteract the recent price decline.
Broader market context shows that while Venus Remedies has outperformed the Sensex over the long term, its short-term performance has been disappointing compared to the benchmark, which has only declined by 2.34% over the past week. The stock's recent struggles may be attributed to broader market conditions, as indicated by its significant underperformance relative to both the sector and the benchmark index. Despite the company's strong fundamentals and positive financial results, the current market sentiment appears to be weighing heavily on the stock, leading to its recent price drop.